Issue 4/2005
Content (14 Articles)
Targeting the silent minority: emerging immunotherapeutic strategies for eradication of malignant stem cells in chronic myeloid leukaemia
M. Copland, A. R. Fraser, S. J. Harrison, T. L. Holyoake
Interaction of PD-L1 on tumor cells with PD-1 on tumor-specific T cells as a mechanism of immune evasion: implications for tumor immunotherapy
Christian Blank, Thomas F. Gajewski, Andreas Mackensen
Carcinoembryonic antigen antibody inhibits lung metastasis and augments chemotherapy in a human colonic carcinoma xenograft
Rosalyn D. Blumenthal, Lou Osorio, Marianne K. Hayes, Ivan D. Horak, Hans J. Hansen, David M. Goldenberg
Acquisition of multidrug resistance by L1210 leukemia cells decreases their tumorigenicity and enhances their susceptibility to the host immune response
Elena Martín-Orozco, José Antonio Ferragut, Pilar Garcia-Peñarrubia, Antonio Ferrer-Montiel
Distribution of labelled anti-tenascin antibodies and fragments after injection into intact or partly resected C6-gliomas in rats
Claudia Maria Goetz, Walter Rachinger, Markus Decker, Franz-Josef Gildehaus, Susanne Stocker, Gundram Jung, Klaus Tatsch, Jörg-Christian Tonn, Hans-Jürgen Reulen
Heterogeneous antibody response to polyvalent melanoma vaccines in syngeneic mice
Dean Johnston, Jean-Claude Bystryn
BCL1 lymphoma protection induced by idiotype DNA vaccination is entirely dependent on anti-idiotypic antibodies
Michela Cesco-Gaspere, Federica Benvenuti, Oscar R. Burrone
Use of selected reaction monitoring mass spectrometry for the detection of specific MHC class I peptide antigens on A3 supertype family members
Kevin T. Hogan, Jennifer N. Sutton, Kyo U. Chu, Jennifer A. C. Busby, Jeffrey Shabanowitz, Donald F. Hunt, Craig L. Slingluff Jr
Uptake and presentation of malignant glioma tumor cell lysates by monocyte-derived dendritic cells
Steven De Vleeschouwer, Mohammed Arredouani, Martine Adé, Pascal Cadot, Elke Vermassen, Jan. L. Ceuppens, Stefaan W. Van Gool
Mycophenolate mofetil does not suppress the graft-versus-leukemia effect or the activity of lymphokine-activated killer (LAK) cells in a murine model
Michael Y. Shapira, Ester Hirshfeld, Lola Weiss, Michael Zeira, Judith Kasir, Reuven Or, Igor B. Resnick, Shimon Slavin
Phenotype and function of human natural killer cells purified by using a clinical-scale immunomagnetic method
Wing Leung, Rekha Iyengar, Thasia Leimig, Marti S. Holladay, James Houston, Rupert Handgretinger
Identification of the protein components of protein-bound polysaccharide (PSK) that interact with NKL cells
Eva Jiménez, Angel Garcia-Lora, Marisol Martinez, Federico Garrido
Expression of MHC class I, MHC class II, and cancer germline antigens in neuroblastoma
Matthias Wölfl, Achim A. Jungbluth, Federico Garrido, Teresa Cabrera, Sharon Meyen-Southard, Rüdiger Spitz, Karen Ernestus, Frank Berthold